NASDAQ Careers: Find a Job Now
Web NASDAQ.com
Search
Save my stocks for next time

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

PURE: Stock Quote & Summary Data

$ 1.96 0.03 1.51%
Nov. 20, 2009 Market Closed
Update Quotes: . Updates every 7 Seconds.
PURE Bioscience
PURE | PURE Bioscience | Common Stock | Market : NASDAQ-CM

Last Sale
Change Net / %
Best Bid / Ask
1y Target Est: $ 8.00
Today's High / Low  / 
Share Volume
50 Day Avg. Daily Volume 148,302
Previous Close $ 1.99
52 Wk High / Low $ 4.10 / $ 1.22
Shares Outstanding 34,126,000
Market Value $ 66,886,960
P/E Ratio NE
Forward P/E (1yr) N/A
Earnings Per Share $ -0.22
Annualized Dividend N/A
Ex Dividend Date N/A
Dividend Payment Date N/A
Current Yield N/A
Beta 0.89
NASDAQ Official Open Price: $ 1.95
Date of NASDAQ Official Open Price: Nov. 20, 2009
NASDAQ Official Close Price: $ 1.96
Date of NASDAQ Official Close Price: Nov. 20, 2009

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

Have a Question About PURE?

Ask your question about about PURE Bioscience (PURE) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!

Hot Topics in NASDAQ Answers

The most popular questions & answers in the
NASDAQ Answers Community:


 Company Description (as filed with the SEC)

PURE Bioscience began as a provider of pharmaceutical water purification products for the pharmacy market. In 2000 we commenced investments in the development of novel bioscience technologies, and subsequent to the May 2005 sale of our Water Treatment Division we have been exclusively focused on the development and commercialization of our current and future bioscience products. We are expanding into markets with broad potential by developing new, proprietary bioscience products based upon our patented silver ion antimicrobial technologies and to a lesser extent our patent-pending boric acid based pesticide technologies. We are developing technology-based bioscience products, including our silver dihydrogen citrate-based antimicrobials, which we believe will provide best in class, non-toxic solutions to numerous global health challenges and represent innovative advances in diverse markets.  ... More ...  

Get ETF News, Commentary, Tools & more...

Visit the new NASDAQ.com ETFs hub Now

 Company News for PURE

Gutenberg Communications Receives Two MarCom Gold Awards from Association of Marketing and Communication Professionals
- Business Wire  11/04/2009 9:00AM
North Canton Company Fights Against H1N1 with New EPA Registered Hard Surface Disinfectant, Formulated for Use Around Children and Pets
- PR Newswire  10/29/2009 11:00AM
EPA-Registered Ionic Silver Disinfectant Effective Against 2009 H1N1 Flu Strain
- Business Wire  10/27/2009 8:27AM
PURE Bioscience Q4 09 Earnings Conference Call At 4:30 PM
- RTT News  10/14/2009 2:17PM
PURE Bioscience Reveals Alliance With Sales And Marketing Team Richmont Sciences, LLC - Quick Facts
- RTT News  10/14/2009 8:56AM
PURE Bioscience Expands Business Strategy with Sales and Marketing Alliance for Long-lasting, Broad Spectrum SDC Antimicrobial Products
- Business Wire  10/14/2009 8:27AM
PURE Bioscience Reports FY09 Loss - Quick Facts
- RTT News  10/13/2009 4:43PM